Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences

Stock Track

02/24

BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.

The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.

Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1104772958"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1104772958\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1104772958?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104772958","market":"hk","top_or_hot":-1,"title":"Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences","media":"Stock Track","content":"<p>BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.</p><p>The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.</p><p>Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-02-24 22:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.</p><p>The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.</p><p>Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BMRN","symbol_name":"拜瑪林製藥","start_time":0,"source_url":"","article_id":"1104772958","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104772958","pubTimestamp":1771944414,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BMRN":"拜玛林制药"},"translate_title":"个股追踪|拜玛林制药盘中大涨5.30%，因分析师正面评级和即将召开的投资者会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMRN":1},"content_text":"BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}